Pharmacovigilance

A Practical Approach

Häftad, Engelska, 2025

Av Thao Doan, Fabio Lievano, Linda Scarazzini, Charles Schubert, Barbara Hendrickson, MD Doan, Thao, PhD H.C. Lievano, Fabio, MD, USA) Scarazzini, Linda, MD (Senior Vice President, Pharmacovigilance and Patient Safety, Epidemiology and R&D Quality Assurance, Chief Safety Officer, AbbVie, North Chicago, IL, USA) Schubert, Charles, MD, MPH (Former Vice President, Oncology, Pharmacovigilance and Patient Safety, Epidemiology and R&D Quality Assurance, AbbVie, North Chicago, IL, USA) Hendrickson, Barbara, MD (Clinical Associate, Department of Pediatrics, University of Chicago, Chicago, IL

1 129 kr

Beställningsvara. Skickas inom 5-8 vardagar

Fri frakt för medlemmar vid köp för minst 249 kr.

Written by multidisciplinary experts in the fields of pharmaceutical and patient safety, Pharmacovigilance: A Practical Approach, Second Edition, provides a succinct, easy-to-digest overview of an increasingly critical area of medical safety. From cover to cover, this concise resource offers essential information for physicians and other health care professionals, clinical researchers, and regulators who need a comprehensive, up-to-date source of information on the principles and practice of pharmacovigilance.

Produktinformation

Utgivningsdatum2025-03-28
Mått191 x 235 x 12 mm
Vikt470 g
FormatHäftad
SpråkEngelska
Upplaga2
FörlagElsevier Health Sciences
ISBN9780443118814

Tillhör följande kategorier

Farmakologi inom Medicin

Thao Doan is Group Medical Director, Pharmacovigilance and Patient Safety, Epidemiology and R&D Quality Assurance, AbbVie, North Chicago, IL, United States; Adjunct Faculty, Loyola University Stritch School of Medicine, Maywood, IL, United States; Adjunct Faculty, Department of Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA Fabio Lievano isVice President, Patient Safety, Scientific Collaborations, and New Business Advancement, Pharmacovigilance and Patient Safety, Epidemiology and, R&D Quality Assurance, AbbVie, North Chicago, IL, United States; Adjunct Faculty, Loyola University Stritch School of Medicine, Maywood, IL, United States; Adjunct Faculty, Northwestern University Feinberg School of Medicine, Chicago, IL, United States. Linda Scarazzini is Senior Vice President, Pharmacovigilance and Patient Safety, Epidemiology and R&D Quality Assurance, Chief Safety Officer, AbbVie, North Chicago, IL, United States. Charles Schubert is former Vice President, Oncology, Pharmacovigilance and Patient Safety, Epidemiology and R&D Quality Assurance, AbbVie, North Chicago, IL, United States. Barbara Hendrickson is Clinical Associate, Department of Pediatrics, University of Chicago, Chicago, IL, United States

SECTION 1 THE REGULATORY ENVIRONMENT AND THE PHARMACOVIGILANCE QUALITY SYSTEM1. Does Regulation Drive Science or Does Science Drive Regulation?SECTION 2 PRECLINICAL SAFETY ASSESSMENT2. Absorption, Distribution, Metabolism and Excretion, Pharmacokinetics, and Safety Pharmacology3. Preclinical Safety Assessment : General and Genetic Toxicology4. PharmacogeneticsSECTION 3 FIRST-IN-HUMAN TRIALS5. Safety Planning for First-in-Human Trials6. Pharmacokinetic and Pharmacodynamic Considerations in Safety EvaluationSECTION 4 SAFETY ASSESSMENT IN CLINICAL TRIALS7. Safety Monitoring in Clinical Trials8. Introduction to Quantitative Methods and Visual Analytics in Drug Safety Data in Clinical Trials9. Product Aggregate Safety Assessment10. Data Monitoring CommitteesSECTION 5 SIGNAL AND RISK MANAGEMENT11. Methods of Signal Detection and Signal Management12. Causality Assessment13. Examples of Adverse Drug Reactions: Drug-Induced Liver Injury, Renal, Skin, Immune-Mediated Events, and Major Adverse Cardiac Events14. Internal Safety Advisory Groups15. Benefit-Risk ManagementSECTION 6 ROLE OF EPIDEMIOLOGY AND REALWORLD EVIDENCE16. Role of Epidemiology and Pharmacoepidemiology in the Biopharmaceutical Industry17. Real-World Pharmacoepidemiology StudiesSECTION 7 SPECIAL POPULATIONS AND SPECIAL TOPICS18. Pharmacovigilance in Pregnancy19. Pharmacovigilance in Pediatrics20. Pharmacovigilance in the Elderly21. Vaccine Pharmacovigilance22. Application of Human Factors and Health Literacy in Pharmacovigilance23. Medical Device Safety Oversight and SurveillanceSECTION 8 THE NEXT FRONTIER24. Information Technology in Pharmacovigilance: Current State and Future Directions25. The Future of Pharmacovigilance